Literature DB >> 1398748

Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells.

S Makino1, H Masutani, N Maekawa, I Konishi, S Fujii, R Yamamoto, J Yodoi.   

Abstract

Adult T-cell leukaemia (ATL)-derived factor (ADF), originally described as an inducer of interleukin-2 receptor-alpha (IL-2R alpha/Tac), has homology with the co-enzyme thioredoxin which is involved in many dithiol-dependent reducing processes. Using antibody against the C-terminal synthetic polypeptide of ADF and RNA probe of ADF, we examined the expression of ADF in various cell lines by immunofluorescence, immunohistochemical staining, Western blotting and in situ hybridization. ADF was intensely expressed on HTLV-I+ T-cell lines as compared with HTLV-I- T-cell lines. While the Epstein-Barr virus (EBV)+ B-lymphoblastoid cell lines were intensely positive for ADF, Burkitt-derived B cell line Jijoye with defective EBV was negative for ADF. Electron microscopic and photomicroscopic analysis of HTLV-I+ ATL-2 cells showed that ADF was localized on both the cell membrane and cytosol. In ATL-2 cells, a marked heterogeneity of ADF expression was observed. In in situ hybridization, heterogeneity of ADF messenger RNA (mRNA) expression was also demonstrated, indicating that ADF expression was regulated in the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398748      PMCID: PMC1421573     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Identification of a thioredoxin-related protein associated with plasma membranes.

Authors:  H Martin; M Dean
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

2.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).

Authors:  J Yodoi; K Teshigawara; T Nikaido; K Fukui; T Noma; T Honjo; M Takigawa; M Sasaki; N Minato; M Tsudo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis.

Authors:  K U Schallreuter; J M Wood
Journal:  Biochem Biophys Res Commun       Date:  1986-04-29       Impact factor: 3.575

4.  Redox regulation of fos and jun DNA-binding activity in vitro.

Authors:  C Abate; L Patel; F J Rauscher; T Curran
Journal:  Science       Date:  1990-09-07       Impact factor: 47.728

5.  Immunoelectron microscopic localization of glutaredoxin and thioredoxin in Escherichia coli cells.

Authors:  H Nygren; B Rozell; A Holmgren; H A Hansson
Journal:  FEBS Lett       Date:  1981-10-12       Impact factor: 4.124

6.  Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.

Authors:  N Wakasugi; Y Tagaya; H Wakasugi; A Mitsui; M Maeda; J Yodoi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells.

Authors:  M Matsuda; H Masutani; H Nakamura; S Miyajima; A Yamauchi; S Yonehara; A Uchida; K Irimajiri; A Horiuchi; J Yodoi
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  Thioredoxin deficiency in yeast prolongs S phase and shortens the G1 interval of the cell cycle.

Authors:  E G Muller
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

9.  Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent.

Authors:  A Yamauchi; H Masutani; Y Tagaya; N Wakasugi; A Mitsui; H Nakamura; T Inamoto; K Ozawa; J Yodoi
Journal:  Mol Immunol       Date:  1992-02       Impact factor: 4.407

10.  Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.

Authors:  M Carlsson; C Sundström; M Bengtsson; T H Tötterman; A Rosén; K Nilsson
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

View more
  2 in total

1.  Nitric oxide and thiol redox regulation of Janus kinase activity.

Authors:  R J Duhé; G A Evans; R A Erwin; R A Kirken; G W Cox; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

2.  Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.

Authors:  T Sasada; S Iwata; N Sato; Y Kitaoka; K Hirota; K Nakamura; A Nishiyama; Y Taniguchi; A Takabayashi; J Yodoi
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.